Market Cap (In EUR)
2.26 Million
Revenue (In EUR)
543 Thousand
Net Income (In EUR)
-28.77 Million
Avg. Volume
12.06 Thousand
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0062-0.189
- PE
- -
- EPS
- -
- Beta Value
- -2.739
- ISIN
- BE0974280126
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Prof. François Rieger
- Employee Count
- -
- Website
- https://www.bonetherapeutics.com
- Ipo Date
- 2022-10-26
- Details
- Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.
More Stocks
-
RASP
-
603798
-
FPNUFFP Newspapers Inc.
FPNUF
-
365550
-
3006
-
600386
-
600986
-
PRECOTPrecot Limited
PRECOT